ArticleESC heart failure2022

Characterization of heart failure patients with reverse left ventricular remodelling post-angiotensin receptor blockers/neprilysin inhibitors therapy.

Leonid Maizels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.